Stay up to date with our newsletter

Get in touch!

To explore career opportunities with Sai Life Sciences, share your CV here.

Lets start the conversation!

Sign up to our newsletter

Thank you!
We will be in touch shortly.

2021.12.20

2021 Sustainability Report of Sai Life Sciences highlights the momentum gained in its Sustainability choices

2021 Sustainability Report of Sai Life Sciences highlights the momentum gained in its Sustainability choices

Sai Life Sciences today announced the release of its 2021 Sustainability Report. Developed as per the Global Reporting Initiative (GRI) standards, the report highlights the momentum gained by the company in its Sustainability choices and elaborates on how the pandemic has helped the company galvanise change in the organization, positively impacting its various stakeholders. The full report can be accessed here.

Making the announcement, Krishna Kanumuri, CEO & Managing Director said, “In a year that was significantly impacted by the Covid-19 pandemic, we made tremendous progress in advancing our Sustainability agenda. The 2021 report describes the momentum we have gained in because of the renewed thrust we have placed in this important sphere.”

The 2021 Report underscores how the company’s organizational transformation initiative, SaiNxt helped it gain momentum on its sustainability choices while highlighting its progress on issues that are critical for its business and stakeholders.

. Exceeded target on the shift towards renewable energy sources
Implemented 10 projects in energy management with cumulative savings of 1.3 million KWh/annum
. Strengthened adoption of green chemistry principles in process development
. Conducted multiple programmes engaging shop floor teams towards operational excellence - KPI monitoring, team effectiveness, Kaizens, rewards & recognition
. Received 5-Star rating for Excellence in EHS Practices at the Confederation of Indian Industry (CII) South awards 2019 & 2020
Manufacturing site recognised as ‘Excellent Energy Efficient Unit’ at CII’s National Energy Management Awards in 2021and 2020 .
.  Won two awards at the prestigious 2021 Association for Talent Development – Excellence in Practice (ATD-EIP) awards.

The report also extensively deals with the impact of the Covid-19 pandemic and how the company dealt with the challenges to ensure employee health & safety and business continuity, while supporting the community in dealing with the pandemic.

SreeKrishna Chopperla, Sr Vice President and Head of HSE said, “The paramount challenge of 2021 was dealing with COVID 19 pandemic. As we improved our performance on various fronts, we also ensured that all our stakeholders got the necessary support and confidence in dealing with the pandemic. As we move forward, we are furthering our commitment to Sustainability with proactive measures such as becoming a signatory to UNGC, aligning to SA 8000 standards, ISO 50001 management standards and redefining our goals post FY 22.”

Recent highlights that exemplify and validate the company’s progress on Sustainability:

. Became a signatory to the United Nations Global Compact (UNGC)
. Won GSK’s Environmental Sustainability Supplier award 2021 in the ‘Primary . Manufacturing’ category
Achieved EcoVadis Silver for Sustainability
Won Gold Award at Brandon Hall Group Excellence Awards under the “Best Advance . in Learning Technology Implementation” category.
. Honoured with the Golden Peacock National Training Award 2021 in the pharmaceutical category.


The 2021 Sustainability Report of Sai Life Sciences can be accessed here.

Share article

More News

2025.09.05

Reviving Kudikunta Lake: Bringing nature and community closer together

As part of its Corporate Social Responsibility initiative, Sai Life Sciences has taken up the development of Kudikunta Lake in Hyderabad, reinforcing its commitment to sustainability and community well-being. The Kudikunta Lake initiative marks a significant step in restoring one of Hyderabad’s key lakes and advancing the cause of sustainable urban living. The company has […]
Read more

2025.09.05

From injections to pills: oral peptides set to transform drug development

In a recent article published in Drug Target Review, Dr Santosh Kulkarni highlights the shift from injections to pills. He writes about how oral peptide therapeutics are overcoming the long-standing challenge of poor bioavailability—bringing us closer to patient-friendly medicines without compromising efficacy. The article highlights the booming peptide drug market and the scientific advances—from chemical […]
Read more

2025.08.28

Sai Life Sciences completes Phase II of Production Block 11 at Bidar site, India, expands capacity to 700 KL

Sai Life Sciences Limited (BSE: 544306 | NSE: SAILIFE), an innovator-focused Contract Research, Development, and Manufacturing Organization (CRDMO), today announced the completion of Phase II of its new Production Block (PB-11) at the company’s flagship API manufacturing facility in Bidar, India (Unit IV). The Phase I of PB-11, with a capacity of 110 KL, was inaugurated […]
Read more

2025.08.20

Sai Life Sciences secures SBTi validation for near-term climate targets

Sai Life Sciences Limited, an innovator focused Contract Research, Development, and Manufacturing Organization (CRDMO), announced that its near-term targets to cut greenhouse gas (GHG) emissions have been validated by the Science Based Targets initiative (SBTi)—a corporate climate action organization that enables companies and financial institutions worldwide to play their part in combating the climate crisis. […]
Read more

2025.08.20

Sai Life Sciences featured in Drug Discovery & Development on trends shaping drug discovery

Sai Life Sciences was recently featured in Drug Discovery & Development, where Dr Maneesh Pingle, Executive Vice President and Head of Discovery Services, shared insights on the emerging trends in pharma sector. A key focus was the impact of GLP 1 agonists in accelerating peptide drug discovery. Dr. Pingle explained how the success of these […]
Read more